Analysts Cut CoStar, Lift IQVIA and Teradyne

CoStar Group took the sharpest hit in today's analyst activity. The real estate data firm was downgraded by the consensus. The average target price fell to $38.89 from $44.05. That is an 11.7% cut. Short interest sits at just under 4% of free float. Bears already have a modest presence.

IQVIA Holdings moved the other way. Analysts pushed the average target to $266.74 from $252.58. That is a $14 upgrade. The clinical research firm has a $35.6bn market cap. With 18 buy ratings and no sells on record, the street is firmly bullish.

Teradyne also saw its target lifted. The chip-testing equipment maker now carries a consensus target of $443.20. Market cap has climbed past $52bn. Teradyne sits in semiconductor testing, a sector benefiting from AI-driven chip demand.

Coca-Cola received a notable target bump too. The consensus average rose to $93.57 from $90.43. That is a 3.5% increase. The move follows the company's recent earnings beat.

Incyte gained ground with analysts raising targets to $121.73 from $118.50. The biotech has 13 hold ratings. The upgrade implies expectations of pipeline progress ahead.